Valuation: Medpace Holdings, Inc.

Capitalization 1.2TCr 1.01TCr 928.1Cr 881.83Cr 1.64TCr 1,09200Cr 1.69TCr 11TCr 4.27TCr 52TCr 4.51TCr 4.42TCr 1,84500Cr P/E ratio 2026 *
25x
P/E ratio 2027 * 22.4x
Enterprise value 1.11TCr 935.87Cr 856.56Cr 813.85Cr 1.51TCr 1,00800Cr 1.56TCr 9.88TCr 3.94TCr 48TCr 4.16TCr 4.08TCr 1,70200Cr EV / Sales 2026 *
3.96x
EV / Sales 2027 * 3.54x
Free-Float
83.69%
Yield 2026 *
-
Yield 2027 * -
1 day-4.96%
1 week-24.50%
Current month-27.22%
1 month-28.75%
3 months-29.67%
6 months-5.75%
Current year-24.52%
1 week 422.56
Extreme 422.565
550.62
1 month 422.56
Extreme 422.565
628.92
Current year 422.56
Extreme 422.565
628.92
1 year 250.05
Extreme 250.05
628.92
3 years 167
Extreme 167
628.92
5 years 126.94
Extreme 126.945
628.92
10 years 21.76
Extreme 21.76
628.92
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
President 51 01/08/2021
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Change 5d. change 1-year change 3-years change Capi.($)
-4.96%-24.50%+29.30%+89.65% 1.2TCr
+0.51%-1.74%-14.93%-6.57% 4.61TCr
-0.61%-0.21%+58.79%+43.68% 3.89TCr
+5.27%+11.66%+38.61%+61.04% 3.62TCr
-2.89%-12.52%-11.80%-20.49% 3TCr
+2.09%+1.53%+136.41%+298.66% 1.89TCr
-0.65%-5.99%+27.50%-4.65% 1.36TCr
-1.20%+0.80%+85.33%+94.37% 1.36TCr
+0.07%-0.75%+167.10%+116.28% 1.37TCr
+0.15%-5.85%+27,082.10%+3,523.54% 1.32TCr
Average -0.21%-3.97%+2,759.84%+419.55% 2.36TCr
Weighted average by Cap. +0.27%-2.51%+1,554.45%+250.12%

Financials

2026 *2027 *
Net sales 280.57Cr 236.46Cr 216.42Cr 205.63Cr 381.28Cr 25TCr 394.17Cr 2.5TCr 996.46Cr 12TCr 1.05TCr 1.03TCr 43TCr 301.89Cr 254.43Cr 232.87Cr 221.26Cr 410.26Cr 27TCr 424.13Cr 2.69TCr 1.07TCr 13TCr 1.13TCr 1.11TCr 46TCr
Net income 49Cr 42Cr 38Cr 36Cr 67Cr 4.48TCr 69Cr 438.64Cr 175.14Cr 2.15TCr 184.94Cr 181.14Cr 7.56TCr 55Cr 46Cr 42Cr 40Cr 75Cr 4.99TCr 77Cr 488.72Cr 195.13Cr 2.4TCr 206.05Cr 201.82Cr 8.42TCr
Net Debt -93Cr -78Cr -72Cr -68Cr -126.03Cr -8.42TCr -130.29Cr -824.94Cr -329.37Cr -4.05TCr -347.81Cr -340.66Cr -14TCr -133.08Cr -112.16Cr -102.66Cr -98Cr -180.85Cr -12TCr -186.97Cr -1.18TCr -472.65Cr -5.81TCr -499.11Cr -488.85Cr -20TCr
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. Its drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.
Employees
6,200
Date Price Change Volume
11/26/11 423.93 $ -4.96% 6,91,454
10/26/10 446.05 $ -15.90% 10,31,659
09/26/09 530.35 $ -2.16% 7,93,171
06/26/06 542.04 $ +0.14% 7,52,521
05/26/05 541.27 $ -3.61% 3,36,302
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
423.93USD
Average target price
490.50USD
Spread / Average Target
+15.70%

Quarterly revenue - Rate of surprise